Show simple item record

dc.contributor.authorGuirguis, Amira
dc.contributor.authorCorkery, John
dc.contributor.authorStair, Jacqueline
dc.contributor.authorKirton, Stewart
dc.contributor.authorZloh, Mire
dc.contributor.authorGoodair, Christine
dc.contributor.authorSchifano, Fabrizio
dc.contributor.authorDavidson, Colin
dc.date.accessioned2015-08-18T09:13:36Z
dc.date.available2015-08-18T09:13:36Z
dc.date.issued2015-06-01
dc.identifier.citationGuirguis , A , Corkery , J , Stair , J , Kirton , S , Zloh , M , Goodair , C , Schifano , F & Davidson , C 2015 , ' Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists ' , Drugs and Alcohol Today , vol. 15 , no. 2 , pp. 93-99 . https://doi.org/10.1108/DAT-03-2015-0012
dc.identifier.issn1745-9265
dc.identifier.otherPURE: 8551249
dc.identifier.otherPURE UUID: 49c8f6c0-6de8-4414-9532-d22bbb2c6767
dc.identifier.otherScopus: 84938688239
dc.identifier.otherORCID: /0000-0001-8255-0660/work/35514495
dc.identifier.urihttp://hdl.handle.net/2299/16271
dc.descriptionThis document is the Accepted Manuscript of the following article: Amira Guirguis, John M. Corkery, Jacqueline L. Stir, Stewart Kirton, Mire Zloh, Christine M. Goodair, Fabrizio Schifano, and Colin Davidson, ‘Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists’, Drugs and Alcohol Today, Vol. 15 (2): 93-99, June 2015. The Version of Record is available online at doi: https://doi.org/10.1108/DAT-03-2015-0012.
dc.description.abstractPurpose: To determine pharmacists’ knowledge of legal highs (novel psychoactive substances; NPS). Approach: A questionnaire was handed out at 2 London pharmacist continuing education events in mid-2014. These events update pharmacists about developments of interest/relevance to the profession and to improve their practice. A total of 54 forms were returned; a response rate of 26%. Findings: Most pharmacists had poor knowledge of NPS and many considered that NPS were not important to their work, with few having had to advise customers in this area. Despite this, the majority thought that they had insufficient information about NPS. There was a negative correlation between the age of the pharmacist and knowledge of NPS. Research Limitations: The sample is a self-selected one drawn from registered pharmacists working in community pharmacies in North West London, and thus does not include hospital pharmacies. Self-selection means that respondents may only reflect those who are interested in the NPS phenomenon and not the wider pharmacy community. The geographical area covered may not be representative of London as a whole, or indeed other parts of the UK or other EU countries. Practical and Social Implications: It is clear that pharmacists do not know much about NPS but would like to know more. This information might improve their practice. Pharmacists, easier to see than general practitioners, could be a useful source of information for NPS misusers. Originality: There have been no previous attempts to gauge the level of knowledge by pharmacists of legal highs/novel psychoactive substances in the UK or elsewhere to our knowledge.en
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofDrugs and Alcohol Today
dc.rightsEmbargoed
dc.subjectLegal Highs
dc.subjectNovel Psychoactive Substances, Internet, Persian language, Online marketing
dc.subjectPharmacists
dc.subjectQuestionnaire
dc.titleSurvey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacistsen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.contributor.institutionPrescription and Illicit Drug Misuse
dc.contributor.institutionPublic Health
dc.contributor.institutionCentre for Research into Topical Drug Delivery and Toxicology
dc.contributor.institutionMedicinal and Analytical Chemistry
dc.contributor.institutionNanopharmaceutics
dc.contributor.institutionCentre for Hazard Detection and Protection Research
dc.contributor.institutionNatural Product Chemistry and Drug Design
dc.contributor.institutionPatient and Medicines Safety
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.description.statusPeer reviewed
dc.date.embargoedUntil2016-06-01
dc.relation.schoolSchool of Life and Medical Sciences
dc.description.versiontypeFinal Accepted Version
dcterms.dateAccepted2015-06-01
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1108/DAT-03-2015-0012
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc/4.0/
rioxxterms.licenseref.startdate2016-06-01
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue
herts.date.embargo2016-06-01
herts.rights.accesstypeEmbargoed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record